193 related articles for article (PubMed ID: 34599801)
21. Autoantibody profile in a cohort of Algerian patients with systemic sclerosis.
Tahiat A; Allam I; Abdessemed A; Mellal Y; Nebbab R; Ladjouze-Rezig A; Djidjik R
Ann Biol Clin (Paris); 2020 Apr; 78(2):126-133. PubMed ID: 32175889
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric autoantibody profiling of patients with systemic sclerosis in Greece.
Liaskos C; Marou E; Simopoulou T; Gkoutzourelas A; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Katsiari CG; Bogdanos DP; Sakkas LI
Mediterr J Rheumatol; 2018 Sep; 29(3):120-126. PubMed ID: 32185313
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th/To autoantigen.
Mahler M; Fritzler MJ; Satoh M
Autoimmun Rev; 2015 Mar; 14(3):254-7. PubMed ID: 25462581
[TBL] [Abstract][Full Text] [Related]
24. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
25. The clinical relevance of autoantibodies in scleroderma.
Ho KT; Reveille JD
Arthritis Res Ther; 2003; 5(2):80-93. PubMed ID: 12718748
[TBL] [Abstract][Full Text] [Related]
26. Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.
D'Aoust J; Hudson M; Tatibouet S; Wick J; ; Mahler M; Baron M; Fritzler MJ
Arthritis Rheumatol; 2014 Jun; 66(6):1608-15. PubMed ID: 24577935
[TBL] [Abstract][Full Text] [Related]
27. Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.
Clark KEN; Campochiaro C; Host LV; Sari A; Harvey J; Denton CP; Ong VH
Sci Rep; 2022 Jul; 12(1):11212. PubMed ID: 35780179
[TBL] [Abstract][Full Text] [Related]
28. Extended autoantibody panel in Turkish patients with early-stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes.
Temiz Karadağ D; Komac A; Erez Y; Birlik AM; Sari A; Akdoğan A; Farisogullari B; Kimyon G; Koc E; Arslan D; Karatas A; Koca SS; Kasifoglu N; Yazici A; Hayran KM; Cefle A
Immun Inflamm Dis; 2023 Dec; 11(12):e1089. PubMed ID: 38134320
[TBL] [Abstract][Full Text] [Related]
29. Autoantibody profiles delineate distinct subsets of scleromyositis.
Leclair V; D'Aoust J; Gyger G; Landon-Cardinal O; Meyer A; O'Ferrall E; Karamchandani J; Massie R; Ellezam B; Satoh M; Troyanov Y; Fritzler MJ; Hudson M;
Rheumatology (Oxford); 2022 Mar; 61(3):1148-1157. PubMed ID: 34146090
[TBL] [Abstract][Full Text] [Related]
30. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study.
Zhang X; Zhang H; Zhao J; Li Y; Wang H; Li C
Clin Rheumatol; 2023 May; 42(5):1297-1306. PubMed ID: 36604358
[TBL] [Abstract][Full Text] [Related]
32. Distinctive autoantibody profile in Mexican Mestizo systemic sclerosis patients.
Rodriguez-Reyna TS; Hinojosa-Azaola A; Martinez-Reyes C; Nuñez-Alvarez CA; Torrico-Lavayen R; García-Hernández JL; Cabiedes-Contreras J
Autoimmunity; 2011 Nov; 44(7):576-84. PubMed ID: 21875377
[TBL] [Abstract][Full Text] [Related]
33. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.
Shah AA; Rosen A; Hummers L; Wigley F; Casciola-Rosen L
Arthritis Rheum; 2010 Sep; 62(9):2787-95. PubMed ID: 20506513
[TBL] [Abstract][Full Text] [Related]
34. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
[TBL] [Abstract][Full Text] [Related]
35. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
[TBL] [Abstract][Full Text] [Related]
36. Clinical and serological features of systemic sclerosis in a Chinese cohort.
Wang J; Assassi S; Guo G; Tu W; Wu W; Yang L; Xiao R; Zhao Y; Chu H; Liu J; Ma Y; Kim SJ; Jin L; Mayes MD; Zou H; Zhou X
Clin Rheumatol; 2013 May; 32(5):617-21. PubMed ID: 23271609
[TBL] [Abstract][Full Text] [Related]
37. [Autoantibodies and their clinical characteristics in systemic sclerosis].
Hamaguchi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
[TBL] [Abstract][Full Text] [Related]
38. Performance evaluation of a commercial line blot assay system for detection of myositis- and systemic sclerosis-related autoantibodies.
Hamaguchi Y; Kuwana M; Takehara K
Clin Rheumatol; 2020 Nov; 39(11):3489-3497. PubMed ID: 32385758
[TBL] [Abstract][Full Text] [Related]
39. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis.
Villalta D; Imbastaro T; Di Giovanni S; Lauriti C; Gabini M; Turi MC; Bizzaro N
Autoimmun Rev; 2012 Dec; 12(2):114-20. PubMed ID: 22776784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]